STOCK TITAN

Unicycive: RA Capital reports 3.09M-share stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Unicycive Therapeutics, Inc. (UNCY) ownership amendment reports that RA Capital Management, L.P., RA Capital Healthcare Fund, L.P., Peter Kolchinsky and Rajeev Shah each reported beneficial ownership of 3,091,590 common shares as of September 30, 2026, with shared voting and dispositive power over that amount and no sole power. These are overlapping reporting-person disclosures, not separate additional holdings: the Fund directly holds the securities, RA Capital is its investment adviser, and Kolchinsky and Shah are managers of RA Capital.

The Fund holds Tranche A, B and C Warrants relating to preferred stock convertible into 1,097,325, 997,568 and 1,596,109 common shares, respectively. A beneficial ownership blocker precludes conversion that would cause the Fund and attribution parties to own more than 9.99% of common stock; the amendment says the Fund is currently prohibited from converting to more than 3,091,590 shares. The narrative gives the ownership percentage as 9.99%; the cover pages round it down to 9.9%. The percentage calculation uses 27,855,257 common shares outstanding as of August 12, 2026.

Beneficial ownership reported by each reporting person 3,091,590 shares As of September 30, 2026; each reported shared voting and dispositive power over this amount.
Beneficial ownership percentage 9.99% Narrative percentage as of September 30, 2026; cover-page entries are rounded down to 9.9%.
Common shares outstanding 27,855,257 shares As of August 12, 2026; denominator cited for the ownership percentage calculation.
Shares convertible from Series A-3 Preferred Stock 1,097,325 shares Underlying Tranche A Warrants held directly by the Fund; subject to the beneficial ownership blocker.
Shares convertible from Series A-4 Preferred Stock 997,568 shares Underlying Tranche B Warrants held directly by the Fund; subject to the beneficial ownership blocker.
Shares convertible from Series A-5 Preferred Stock 1,596,109 shares Underlying Tranche C Warrants held directly by the Fund; subject to the beneficial ownership blocker.
Beneficial Ownership Blocker regulatory
"precludes the conversion of the Preferred Stock"
A beneficial ownership blocker is a legal or structural device that prevents a shareholder from being treated as the ultimate owner of enough shares to trigger control, reporting, or voting thresholds. Think of it like a speed bump that stops an investor from reaching a stake size that would force corporate disclosure or change control rights. Investors care because it affects who controls the company, how shares vote, regulatory filings, takeover risk and therefore potential value or liquidity of their holdings.
Tranche A Warrants financial
"The Fund directly holds (i) Tranche A Warrants"
Series A-3 Convertible Preferred Stock financial
"shares of Series A-3 Convertible Preferred Stock"
shared voting power regulatory
"Shared Voting Power 3,091,590.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared Dispositive Power 3,091,590.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many UNCY shares did the reporting persons report owning?

Each of the four reporting persons reported beneficial ownership of 3,091,590 common shares as of September 30, 2026. The entries describe overlapping reporting-person positions: the Fund directly holds the securities, and the other reporting persons’ disclosures relate to that same reported position.

What is the UNCY beneficial ownership blocker?

The blocker precludes conversion of preferred stock to the extent the Fund, together with its affiliates and other attribution parties, would own more than 9.99% of UNCY common stock. The amendment states that the Fund is currently prohibited from converting to more than 3,091,590 common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





90466Y202

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



RA Capital Management, L.P.
Signature:/s/ Peter Kolchinsky
Name/Title:By Peter Kolchinsky, Authorized Signatory
Date:11/16/2026
Peter Kolchinsky
Signature:/s/ Peter Kolchinsky
Name/Title:Peter Kolchinsky
Date:11/16/2026
Rajeev Shah
Signature:/s/ Rajeev Shah
Name/Title:Rajeev Shah
Date:11/16/2026
RA Capital Healthcare Fund, L.P.
Signature:/s/ Peter Kolchinsky
Name/Title:By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager
Date:11/16/2026
Exhibit Information

Exhibit 99.1 Joint Filing Agreement (incorporated by reference to Exhibit 99.1 to the Reporting Persons' Schedule 13G/A filed with the SEC on May 15, 2025).

Keep reading